Xavier Vidal

6.8k total citations · 2 hit papers
123 papers, 4.9k citations indexed

About

Xavier Vidal is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Geriatrics and Gerontology. According to data from OpenAlex, Xavier Vidal has authored 123 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 20 papers in Pharmacology and 17 papers in Geriatrics and Gerontology. Recurrent topics in Xavier Vidal's work include Pharmaceutical Practices and Patient Outcomes (16 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). Xavier Vidal is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (16 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). Xavier Vidal collaborates with scholars based in Spain, Palestinian Territory and Italy. Xavier Vidal's co-authors include Joan‐Ramon Laporte, Luisa Ibáñez, Elena Ballarín, Lourdes Vendrell, Dolors Capellà, Miguel Casas, Xavier Castells, Antònia Agustí, Xavier Carné and Vı́ctor Moreno and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Xavier Vidal

117 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease

2014 429 citations Xavier Vidal et al. profile →
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome

2019 204 citations Xavier Vidal et al. profile →

Peers

Countries citing papers authored by Xavier Vidal

Since Specialization

Citations

This map shows the geographic impact of Xavier Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Vidal more than expected).

Fields of papers citing papers by Xavier Vidal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Vidal. The network helps show where Xavier Vidal may publish in the future.

Co-authorship network of co-authors of Xavier Vidal

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Vidal. A scholar is included among the top collaborators of Xavier Vidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Vidal. Xavier Vidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma 2025 ·JAMA Network Open ·Lina Camacho-Arteaga, Gloria Iacoboni, Mi Kwon, Rebeca Bailén, Rafael Hernani, (unknown), Lucía López‐Corral, (unknown), (unknown), (unknown), (unknown), Aitana Balaguer‐Roselló, (unknown), Xavier Vidal, Pere Barba, Antònia Agustí	0
2	Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study 2022 ·Annals of Medicine ·Narmeen Mallah, Maruxa Zapata‐Cachafeiro, C Aguirre, (unknown), (unknown), (unknown), María Piñeiro‐Lamas, Luisa Ibáñez, Xavier Vidal, Lourdes Vendrell, Luis H. Martín Arias, María Sáinz-Gil, (unknown), (unknown), Ángel Salgado‐Barreira, Ana Estany‐Gestal, Adolfo Figueiras	4
3	Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial 2022 ·Enfermedades infecciosas y microbiologia clinica (English ed ) ·Antònia Agustí, Elena Guillén‐Gómez, (unknown), Andrés Antón, Cristina Aguilera, Xavier Vidal, Cristina Andrés, (unknown), Meritxell Espuga, Juliana Esperalba, (unknown), (unknown), Esteban Ribera	1
4	Efficacy and safety of hydroxychloroquine in healthcare professionals with mild SARS-CoV-2 infection: Prospective, non-randomized trial 2020 ·Enfermedades Infecciosas y Microbiología Clínica ·Antònia Agustí, (unknown), (unknown), Andrés Antón, Cristina Aguilera, Xavier Vidal, Cristina Andrés, (unknown), Meritxell Espuga, Juliana Esperalba, (unknown), Benito Almirante, Esteban Ribera	5
5	Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban—A European comparative drug utilization study 2020 ·Basic & Clinical Pharmacology & Toxicology ·Marietta Rottenkolber, Sven Schmiedl, Luisa Ibáñez, Mònica Sabaté, Elena Ballarín, Xavier Vidal, Luz M. León‐Muñoz, Consuelo Huerta, Elisa Martín‐Merino, Dolores Montero, Christiane Gasse, Morten Andersen, (unknown), Marie L. De Bruin, (unknown), Martin Tauscher, Patrick C. Souverein, (unknown), Olaf H. Klungel, Helga Gardarsdóttir	3
6	Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis 2020 ·International Journal of Antimicrobial Agents ·Teodoro J. Oscanoa, Xavier Vidal, Jørgen K. Kanters, Román Romero‐Ortuño	11
7	Study of antidepressant use in 5 European settings. Could economic, sociodemographic and cultural determinants be related to their use? 2019 ·Journal of Affective Disorders ·Ainhoa Gómez-Lumbreras, (unknown), Elena Ballarín, Mònica Sabaté, Xavier Vidal, Margherita Andretta, (unknown), Luisa Ibáñez	28
8	Efficacy of radial extracorporeal shock wave therapy compared to botulinum toxin type a in the treatment of lower extremity spasticity in patients with cerebral palsy 2018 ·Annals of Physical and Rehabilitation Medicine ·Xavier Vidal, (unknown), Olga Canet Vélez, Marta Roqué i Figuls, Antoni Morral, (unknown), Christoph Schmitz, (unknown)	0
9	Inappropriate prescribing in elderly people with diabetes admitted to hospital 2015 ·Diabetic Medicine ·Françesc Formiga, Xavier Vidal, Antònia Agustí, David Chivite, Beatriz Rosón, Jordi Barbé, Alfonso López‐Soto, Olga H. Torres, Antonio Fernández-Moyano, (unknown), Nieves Ramírez‐Duque, (unknown), (unknown)	36
10	Evaluación de la respuesta y seguridad a diferentes esquemas de tratamiento antirretroviral en Colombia 2013 ·Jorge Enrique Machado‐Alba, Xavier Vidal	2
11	Efficacy of indirect dopamine agonists for psychostimulant dependence: A systematic review and meta-analysis of randomized controlled trials 2010 ·Journal of Substance Abuse Treatment ·Clara Pérez‐Mañá, Xavier Castells, Xavier Vidal, Miguel Casas, Dolors Capellà	25
12	Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting 2010 ·British Journal of Clinical Pharmacology ·(unknown), E. Pérez, Sergio Abanades, Xavier Vidal, Cristina Saura, Margarita Majem, Edurne Arriola, (unknown), Antoni Pastor, Magı́ Farré, (unknown), Joan‐Ramon Laporte, Dolors Capellà	105
13	An Intervention to Improve Spontaneous Adverse Drug Reaction Reporting by Hospital Physicians 2009 ·Drug Safety ·Consuelo Pedrós, Antonio Vallano, (unknown), (unknown), Antònia Agustí, Cristina Aguilera, Imma Danés, Xavier Vidal, Josep Arnau	70
14	Epidemiology of aplastic anemia: a prospective multicenter study 2008 ·Haematologica ·Eva Montané, Luisa Ibáñez, Xavier Vidal, Elena Ballarín, Rocío Puig, Nelda Garcia, J R Laporte, (unknown)	126
15	Radiologic Assessment of All Unfused Lumbar Segments 7.5 Years After Instrumented Posterior Spinal Fusion 2007 ·Spine ·Ferrán Pellisé, A. Hernández, Xavier Vidal, Joan Minguell, (unknown), Carlos Villanueva	72
16	Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease 2005 ·Kidney International ·(unknown), (unknown), Xavier Vidal, (unknown), Joan‐Ramon Laporte	28
17	From clinical trials to clinical practice: oral anticoagulation among patients with non-rheumatic, atrial fibrillation 1997 ·European Journal of Clinical Pharmacology ·(unknown), Assumpta Ferrer, Antònia Agustí, Xavier Vidal, (unknown), J R Laporte	12
18	Energy-Dispersive X-Ray Analysis and Scanning Electron Microscopy of Pleura. Study of Reference, Exposed Non-Pneumoconiotic, and Silicotic Populations 1994 ·American Journal of Respiratory and Critical Care Medicine ·Jaume Ferrer, Ramón Orriols, (unknown), (unknown), Carme Xaus, Xavier Vidal	12
19	Therapeutic consultation: a necessary adjunct to independent drug information. 1993 ·British Journal of Clinical Pharmacology ·C. Rodríguez, (unknown), Xavier Vidal, Joan‐Ramon Laporte	8
20	[Therapeutic consultation: information oriented to clinical problems]. 1989 ·PubMed ·Charo Rodríguez, (unknown), (unknown), Xavier Vidal	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact